These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 30082470)
1. Phage Display-Derived Peptide-Based Dual-Modality Imaging Probe for Bladder Cancer Diagnosis and Resection Postinstillation: A Preclinical Study. Peng L; Shang W; Guo P; He K; Wang H; Han Z; Jiang H; Tian J; Wang K; Xu W Mol Cancer Ther; 2018 Oct; 17(10):2100-2111. PubMed ID: 30082470 [TBL] [Abstract][Full Text] [Related]
2. A clinical study of a CD44v6-targeted fluorescent agent for the detection of non-muscle invasive bladder cancer. Shang W; Peng L; He K; Guo P; Deng H; Liu Y; Chen Z; Tian J; Xu W Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3033-3045. PubMed ID: 35190862 [TBL] [Abstract][Full Text] [Related]
3. Targeting tumour surface collage with hydrogel probe: a new strategy to enhance intraoperative imaging sensitivity and stability of bladder cancer. Guo P; Qi A; Shang W; Cai Z; Hu S; Dai P; Chen Z; Sun M; Wang Z; Tong Z; Hou D; Wang Z; Du Y; Tian J; Xu W Eur J Nucl Med Mol Imaging; 2024 Nov; 51(13):4165-4176. PubMed ID: 39060372 [TBL] [Abstract][Full Text] [Related]
4. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma. Baart VM; van der Horst G; Deken MM; Bhairosingh SS; Schomann T; Sier VQ; van der Mark MH; Iamele L; de Jonge H; Resnati M; Mazar AP; Pelger RCM; van der Pluijm G; Kuppen PJK; Vahrmeijer AL; Sier CFM Eur J Cancer; 2021 Mar; 146():11-20. PubMed ID: 33561783 [TBL] [Abstract][Full Text] [Related]
5. A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo. Yang X; Zhang F; Luo J; Pang J; Yan S; Luo F; Liu J; Wang W; Cui Y; Su X Oncol Rep; 2016 Jul; 36(1):79-89. PubMed ID: 27221614 [TBL] [Abstract][Full Text] [Related]
6. NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe. Wang B; Tang C; Lin E; Jia X; Xie G; Li P; Li D; Yang Q; Guo X; Cao C; Shi X; Zou B; Cai C; Tian J; Hu Z; Li J EBioMedicine; 2023 Dec; 98():104880. PubMed ID: 38035463 [TBL] [Abstract][Full Text] [Related]
7. New optical imaging technologies for bladder cancer: considerations and perspectives. Liu JJ; Droller MJ; Liao JC J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT. Heer R; Lewis R; Duncan A; Penegar S; Vadiveloo T; Clark E; Yu G; Mariappan P; Cresswell J; McGrath J; N'Dow J; Nabi G; Mostafid H; Kelly J; Ramsay C; Lazarowicz H; Allan A; Breckons M; Campbell K; Campbell L; Feber A; McDonald A; Norrie J; Orozco-Leal G; Rice S; Tandogdu Z; Taylor E; Wilson L; Vale L; MacLennan G; Hall E Health Technol Assess; 2022 Oct; 26(40):1-144. PubMed ID: 36300825 [TBL] [Abstract][Full Text] [Related]
9. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice. Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998 [TBL] [Abstract][Full Text] [Related]
10. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery. Tang C; Du Y; Liang Q; Cheng Z; Tian J Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075 [TBL] [Abstract][Full Text] [Related]
11. Correction: Phage Display-Derived Peptide-Based Dual-Modality Imaging Probe for Bladder Cancer Diagnosis and Resection Postinstillation: A Preclinical Study. Peng L; Shang W; Guo P; He K; Wang H; Han Z; Jiang H; Tian J; Wang K; Xu W Mol Cancer Ther; 2024 Nov; 23(11):1681. PubMed ID: 39492663 [No Abstract] [Full Text] [Related]
12. Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer. Wang J; Fang R; Wang L; Chen G; Wang H; Wang Z; Zhao D; Pavlov VN; Kabirov I; Wang Z; Guo P; Peng L; Xu W Cell Physiol Biochem; 2018; 47(4):1565-1577. PubMed ID: 29949785 [TBL] [Abstract][Full Text] [Related]
13. An Innovation for Treating Orthotopic Pancreatic Cancer by Preoperative Screening and Imaging-Guided Surgery. Han Z; Shang W; Liang X; Yan H; Hu M; Peng L; Jiang H; Fang C; Wang K; Tian J Mol Imaging Biol; 2019 Feb; 21(1):67-77. PubMed ID: 29858735 [TBL] [Abstract][Full Text] [Related]
17. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343 [TBL] [Abstract][Full Text] [Related]
18. Near-infrared spectroscopy as a novel method of ex vivo bladder cancer tissue characterisation. Yim A; Alberto M; Sharma V; Green A; Mclean A; du Plessis J; Wong LM; Wood B; Ischia J; Raman J; Bolton D BJU Int; 2024 Apr; 133 Suppl 4():44-52. PubMed ID: 38238965 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of bladder microvasculature with high-resolution photoacoustic imaging. Xie Z; Roberts W; Carson P; Liu X; Tao C; Wang X Opt Lett; 2011 Dec; 36(24):4815-7. PubMed ID: 22179893 [TBL] [Abstract][Full Text] [Related]
20. Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma. Aayush A; Darji S; Dhawan D; Enstrom A; Broman MM; Idrees MT; Kaimakliotis H; Ratliff T; Knapp D; Thompson D Oncotarget; 2022; 13():1004-1016. PubMed ID: 36082359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]